Panel Discussion – Thinking Strategically About What Targets You Select

Time: 3:30 pm
day: Day One


  • Understanding where your target choice and ADC fits into the ADC and wider oncology landscape?
  • How do you differentiate yourself through using improved linker-payload technologies on previously validated targets?
  • Balancing risk in your pipeline through your target choice
  • Novel targets or previously validated targets?
  • Discussing the role of future HER2 ADCs